Compare products Close window [X]

 
 
  Remove Remove Remove Remove Remove Remove
Fluticasone Impurity 9
Amorolfine EP Impurity M
N-Nitroso Imatinib EP Impurity C (Possibility 1)
Raloxifene EP Impurity A
N-Nitroso Imatinib EP Impurity C (Possibility 2)
Avacopan D8
Title Fluticasone Impurity 9 Amorolfine EP Impurity M N-Nitroso Imatinib EP Impurity C (Possibility 1) Raloxifene EP Impurity A N-Nitroso Imatinib EP Impurity C (Possibility 2) Avacopan D8
Add to cart
Description

Fluticasone Impurity 9 is chemically (6S,9R,10S,11S,13S,16R,17R)-6,9-Difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic (6S,9R,11S,13S,16R,17R)-6,9-difluoro-11,17-dihydroxy-13,16-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic dithioperoxyanhydride.
Fluticasone Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Fluticasone Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluticasone.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Amorolfine EP Impurity M is chemically Mixture of (1RS,2RS)-3-[(2RS,6SR)-2,6-dimethylmorpholin-4-yl]-2-methyl-1-[4-(2-methylbutan-2-yl)phenyl]propan-1-ol and (1RS,2SR)-3-[(2RS,6SR)-2,6-dimethylmorpholin-4-yl]-2-methyl-1-[4-(2-methylbutan-2-yl)phenyl]propan-1-ol (as per EP).
Amorolfine EP Impurity M is supplied with detailed characterization data compliant with regulatory guideline. Amorolfine EP Impurity M can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Amorolfine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

N-Nitroso Imatinib EP Impurity C (Possibility 1)is chemically N-(4-methyl-3-(nitroso(4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(piperazin-1-ylmethyl)benzamide 2,2,2-trifluoroacetate. N-Nitroso Imatinib EP Impurity C (Possibility 1) is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Imatinib EP Impurity C (Possibility 1) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Raloxifene EP Impurity A is chemically (6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophene-3,7-diyl)bis((4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;.
It is also known as Raloxifene Diketone.
Raloxifene EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Raloxifene EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Raloxifene.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

N-Nitroso Imatinib EP Impurity C (Possibility 2)is chemically N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-nitrosopiperazin-1-yl)methyl)benzamide. N-Nitroso Imatinib EP Impurity C (Possibility 2) is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Imatinib EP Impurity C (Possibility 2) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Avacopan D8 is chemically (2R,3S)-2-(4-((cyclopentyl-2,2,3,3,4,4,5,5-d8)amino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide.
Avacopan D8 is supplied with detailed characterization data compliant with regulatory guideline. Avacopan D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avacopan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.

Availability In stock In stock In stock In stock In stock In stock
CAS No       1159977-58-8 2816369-80-7 2316781-77-6
Inv. Status Custom Synthesis Custom Synthesis Inquire In Stock In Stock Custom Synthesis
Mol.F. C41H48F4O8S2 C21H35NO2 C28H28N8O2 C42H44N2O6S C28H28N8O2 C33H27D8F4N3O2
ISP CAT No ISP-F016057 ISP-A068014 ISP-I004060 ISP-R007002 ISP-I004061 ISP-A174D01
Mol.Wt. 808.9 333.5 508.6 704.9 508.6 589.7